Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols

Claudia Bello, Giovanna Dal Bello, Michele Cea, Aimable Nahimana, Dominique Aubry, Anna Garuti, Giulia Motta, Eva Moran, Floriana Fruscione, Paolo Pronzato, Francesco Grossi, Franco Patrone, Alberto Ballestrero, Marc Dupuis, Bernard Sordat, Kaspar Zimmermann, Jacqueline Loretan, Markus Wartmann, Michel A. Duchosal, Alessio NencioniPierre Vogel

Research output: Contribution to journalArticlepeer-review


New derivatives of 1,4-dideoxy-1,4-imino-d-ribitol have been prepared and evaluated for their cytotoxicity on solid and haematological malignancies. 1,4-Dideoxy-5-O-[(9Z)-octadec-9-en-1-yl]-1,4-imino-d-ribitol (13, IC 50 ∼2 μM) and its C 18-analogues (IC 50 50 ∼8 μM) growth of JURKAT cells.

Original languageEnglish
Pages (from-to)7720-7727
Number of pages8
JournalBioorganic and Medicinal Chemistry
Issue number24
Publication statusPublished - Dec 15 2011


  • Breast cancer
  • Iminoalditols
  • JURKAT cells
  • Oleyl derivative

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry


Dive into the research topics of 'Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols'. Together they form a unique fingerprint.

Cite this